Form D · Other
Ravenquest Biomed Inc.
Vancouver, A1 · CIK 0001719252
Offering snapshot reported Apr 2, 2019 · SEC filing
- Reported sold
- $315K Offering amount: $1.37M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2019 | Initial | $314,796 | No comparison | 2 | SEC filing |
| Sep 10, 2018 | Initial | $326,855 | No comparison | 4 | SEC filing |
| Mar 20, 2018 | Initial | $615,777 | No comparison | 3 | SEC filing |
| Oct 12, 2017 | Initial | $864,805 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336192
THE ADDITIONAL $1,056,466 MAY BE RECEIVED UPON THE EXERCISE OF SHARE PURCHASE WARRANTS SOLD INSIDE AND OUTSIDE THE U.S. U.S. DOLLAR AMOUNTS ARE BASED ON THE BANK OF CANADA AVERAGE RATE OF EXCHANGE REPORTED ON MARCH 15, 2019, WHICH WAS CDN$1.3342=USD$1.00.
EACH UNIT IS COMPRISED OF ONE COMMON SHARE AND ONE-HALF OF ONE COMMON SHARE PURCHASE WARRANT. EACH WARRANT IS EXERCISABLE FOR ONE COMMON SHARE AT AN EXERCISE PRICE OF CDN$0.80 PER SHARE FOR A PERIOD OF 24 MONTHS, SUBJECT TO ACCELERATION.
Source: Form D, filed Apr 2, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris Bechtel | Director |
| Chris Betchel | Director |
| Jorge Bonet | Director |
| David Cross | Executive |
| Anton J. Drescher | Director |
| Marla Ritchie | Executive |
| George Robinson | Director, Executive |
| Henk Van Alphen | Director |
| Hendrik Van Alphen | Director |
Issuer details
Industry: Other (See others in industry)
Address:
Suite 780 580 Hornby Street
Vancouver, A1, V6C 3B6
Vancouver, A1, V6C 3B6